FIBROGEN INC - Common Stock, $0.01 par value (FGEN) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2014 to Q3 2025

Type / Class: Equity / Common Stock, $0.01 par value
Symbol: FGEN on Nasdaq
Shares outstanding: 100,740,741
Price per share: $0.31
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 0
Total reported value: $0
Share change: -15,000
Value change: -$79,500
Number of holders: 0

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ARMISTICE CAPITAL, LLC	8.4%	+24%	$2,805,000	+$561,000	8,500,000	+25%	Armistice Capital, LLC	31 Mar 2025
PRIMECAP MANAGEMENT CO/CA/	4.6%		$1,523,323		4,616,130		PRIMECAP MANAGEMENT CO/CA/	31 Dec 2024

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of FIBROGEN INC - Common Stock, $0.01 par value (FGEN). This represents 0% of the company’s total 100,740,741 outstanding shares.

Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q3	0	$0	-$79,500			$0.31	0
2025 Q2	15,000	$79,500	-$10,137,427	$0	$0	$5.30	1
2025 Q1	32,974,661	$10,217,322	-$1,814,128	$31,741	$131,917	$0.31	52
2024 Q4	36,261,009	$19,199,469	-$4,577,110	$55,842	$167,345	$0.53	65
2024 Q3	45,933,468	$18,857,141	-$6,430,829	$268,384	$140,567	$0.40	68
2024 Q2	56,537,431	$50,439,989	-$9,081,706	$807,837	$1,881,657	$0.89	100
2024 Q1	61,231,274	$143,890,300	-$18,865,510	$518,880	$3,536,515	$2.35	106
2023 Q4	70,070,394	$62,097,852	+$1,475,033	$58,053	$1,671,266	$0.89	99
2023 Q3	68,326,642	$58,948,042	-$26,264,926	$54,190	$1,667,977	$0.86	106
2023 Q2	76,278,245	$205,953,752	-$161,076,321	$10,365,770	$20,623,520	$2.70	149
2023 Q1	76,360,130	$1,424,871,632	+$28,986,682	$7,029,222	$39,617,046	$18.66	171
2022 Q4	74,882,455	$1,199,512,447	+$34,809,045	$3,066,228	$31,551,390	$16.02	143
2022 Q3	73,058,455	$950,485,507	+$31,367,178	$2,912,000	$26,798,350	$13.01	146
2022 Q2	70,661,940	$746,891,350	+$29,354,270	$2,367,000	$20,989,000	$10.56	145
2022 Q1	67,898,538	$816,547,036	+$18,128,716	$2,524,000	$3,552,000	$12.02	150
2021 Q4	66,279,662	$934,552,606	+$30,528,224	$3,964,000	$4,280,000	$14.10	157
2021 Q3	64,052,510	$654,426,634	-$173,048,089	$4,431,000	$3,664,000	$10.22	156
2021 Q2	67,744,971	$1,804,059,935	-$97,241,940	$52,400,959	$68,083,281	$26.63	170
2021 Q1	71,176,129	$2,470,272,742	-$31,512,282	$29,219,000	$6,921,000	$34.71	190
2020 Q4	71,979,588	$2,669,848,746	+$83,550,338	$25,062,000	$42,516,000	$37.09	202
2020 Q3	68,946,106	$2,836,067,721	+$69,119,809	$21,484,000	$16,338,000	$41.12	205
2020 Q2	67,276,990	$2,726,519,660	+$109,940,747	$17,528,000	$17,004,000	$40.53	188
2020 Q1	64,502,523	$2,241,446,114	+$113,121,712	$16,707,000	$10,324,000	$34.75	183
2019 Q4	61,421,765	$2,634,618,707	+$38,703,669	$21,534,000	$34,148,000	$42.89	208
2019 Q3	60,775,042	$2,247,652,301	-$21,551,953	$14,545,000	$28,722,000	$36.98	207
2019 Q2	61,289,161	$2,767,887,727	+$155,500,176	$15,276,000	$19,056,000	$45.18	188
2019 Q1	57,939,233	$3,149,200,949	+$65,047,180	$59,992,000	$14,604,000	$54.35	221
2018 Q4	56,762,525	$2,626,788,611	-$105,914,649	$18,937,000	$19,923,000	$46.28	193
2018 Q3	55,858,822	$3,393,439,085	-$20,598,295	$26,420,000	$5,072,000	$60.75	184
2018 Q2	56,215,445	$3,519,052,177	+$181,537,369	$27,638,000	$8,288,000	$62.60	191
2018 Q1	53,304,011	$2,461,921,610	+$130,270,299	$24,805,000	$6,401,000	$46.20	191
2017 Q4	50,164,786	$2,377,778,005	+$98,540,023	$22,264,000	$6,237,000	$47.40	184
2017 Q3	47,853,028	$2,575,637,958	+$551,224,666	$30,214,000	$9,778,000	$53.80	178
2017 Q2	37,906,037	$1,224,325,864	+$269,590,730	$10,381,000	$2,328,000	$32.30	148
2017 Q1	31,065,653	$765,766,533	+$132,773,177	$6,876,000	$1,261,000	$24.65	141
2016 Q4	30,158,684	$645,408,993	-$11,768,672	$5,061,000	$2,615,000	$21.40	135
2016 Q3	30,813,510	$637,314,781	-$11,901,357	$2,006,000	$2,457,000	$20.70	130
2016 Q2	31,596,562	$518,493,981	-$37,231,328	$936,000	$661,000	$16.41	142
2016 Q1	32,866,063	$699,483,000	+$21,624,319	$2,996,000	$4,739,000	$21.29	133
2015 Q4	31,602,316	$963,138,246	+$96,196,195	$2,474,000	$2,525,000	$30.47	134
2015 Q3	28,567,119	$626,149,001	+$76,703,412	$1,843,000	$1,997,000	$21.92	114
2015 Q2	24,227,264	$569,258,893	+$191,161,902	$1,086,000	$1,525,000	$23.50	93
2015 Q1	15,163,150	$469,917,602	+$11,939,137			$31.38	74
2014 Q4	14,814,221	$399,875,130	+$388,893,130			$27.34	65